elvn-001
elvn-001: sourced relationships with 1 company · 2 clinical trials tracked.
elvn-001 evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could elvn-001 → ELVN affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Enliven Therapeutics, Inc. (ELVN) CML (Chronic Myelogenous Leukemia); Chronic Myeloid Leukemia | Phase 1 |
Clinical Trial Registry Records (2)
A Phase 1 Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
Primary endpoint: Part 1: Incidence of dose limiting toxicities
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia
Primary endpoint: Phase 1a: Incidence of dose limiting toxicities
Frequently asked questions
Which companies have sourced relationships with elvn-001?
elvn-001 has dated SEC/FDA relationship records for Enliven Therapeutics, Inc..
How many clinical trials involve elvn-001?
BioSniper tracks 2 clinical trials involving elvn-001.